Seeing Is Believing
PTGX is currently covered by 6 analysts with an average price target of $55.45. This is a potential upside of $16.79 (43.43%) from yesterday's end of day stock price of $38.66.
Protagonist Therapeutics's activity chart (see below) currently has 68 price targets and 89 ratings on display. The stock rating distribution of PTGX is 97.14% BUY and 2.86% HOLD.
Analysts average stock forecasts to be materialized ratio is 65.62% with an average time for these price targets to be met of 382.86 days.
Highest price target for PTGX is $67, Lowest price target is $53, average price target is $51.17.
Most recent stock forecast was given by DOUGLAS TSAO from HC WAINWRIGHT on 24-Feb-2025. First documented stock forecast 06-Sep-2016.
Currently out of the existing stock ratings of PTGX, 34 are a BUY (97.14%), 1 are a HOLD (2.86%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$54
$16.41 (43.66%)
$50
8 days ago
(24-Feb-2025)
17/26 (65.38%)
$15.25 (39.35%)
264
Buy
$58
$20.41 (54.30%)
$43
25 days ago
(07-Feb-2025)
9/10 (90%)
$19.12 (49.18%)
185
Buy
$53
$15.41 (40.99%)
$48
1 months ago
(04-Feb-2025)
3/4 (75%)
$15.42 (41.03%)
163
Hold
$67
$29.41 (78.24%)
$51
3 months 10 days ago
(22-Nov-2024)
2/5 (40%)
$20.54 (44.21%)
629
Buy
$35
$-2.59 (-6.89%)
$35
1 years 8 months 1 days ago
(03-Jul-2023)
3/10 (30%)
$12.69 (56.88%)
557
What is PTGX (Protagonist Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on PTGX (Protagonist Therapeutics) with a proven track record?
Which analyst has the most public recommendations on PTGX (Protagonist Therapeutics)?
Which analyst is the currently most bullish on PTGX (Protagonist Therapeutics)?
Which analyst is the currently most reserved on PTGX (Protagonist Therapeutics)?